López, Ricardo C. https://orcid.org/0000-0002-1136-9511
Noble, Natalie https://orcid.org/0000-0001-8127-9741
Özçete, Özge D. https://orcid.org/0000-0003-0717-7936
Silenzi, Leonardo
Cai, Xintong
Handy, Gillian E.
Andersen, Jonathan W.
Patriarchi, Tommaso https://orcid.org/0000-0001-9351-3734
Li, Yulong https://orcid.org/0000-0002-9166-9919
Kaeser, Pascal S. https://orcid.org/0000-0002-1558-1958
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS103484)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS083898)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA056109)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA058777)
National Science Foundation (DGE2140743)
Harvard Medical School (NA)
Human Frontier Science Program (LT0004/2022)
Department of Neurobiology, Harvard Medical School (Quan Fellowship)
Department of Neurobiology, Harvard Medical School (Quan Fellowship)
Article History
Received: 6 November 2024
Accepted: 15 June 2026
First Online: 5 August 2026
Ethics
Competing interests: Y.L. is listed as an inventor on a patent application (PCT/CN2018/107533) describing GPCR-based probes. T.P. is listed as an inventor on a patent application (PCT/US17/62993) describing GPCR-based probes. The other authors declare no competing interests.